(Q44321265)

1 December 2017

Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines (English)

1 reference

1 December 2017

hepatocellular carcinoma

1 reference

1 reference

Myung-Ae Bae

1

1 reference

PubMed ID

12595159

1 December 2017

Herman Rhee

series ordinal

2

1 reference

PubMed ID

12595159

1 December 2017

Byoung J Song

series ordinal

3

1 reference

1 December 2017

1 March 2003

1 reference

1 December 2017

1 reference

1 December 2017

139

1 reference

1 December 2017

67-75

1 reference

1 December 2017

1

1 reference

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Thiazolidinediones: a new class of antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Hepatic failure in a patient taking rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Troglitazione affects survival of human osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Toxic effect of troglitazone on cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2802%2900468-X

7 January 2021

10.1016/S0378-4274(02)00468-X

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12595159